Digital Twins aren’t just the future of biomanufacturing—they’re the key to staying competitive today. But with tight timelines, evolving regulations, and resource constraints, implementation can feel overwhelming. In Part 2 of this four-part series, Rich Motruk outlines a proven roadmap to help you navigate the complexities of Digital Twin implementation, based on Kymanox’s industry expertise ✅ Define clear goals – Align stakeholders and set measurable success criteria. ✅ Select the right tech – Partner with industry leaders like Siemens, Dassault, Cytiva. ✅ Run a pilot study – Validate improvements before full-scale deployment. ✅ Scale with confidence – Optimize yields, reduce deviations, and future-proof operations. Read the blog for detailed steps to ensure your Digital Twin’s success: https://lnkd.in/eTxYGhTS #Biomanufacturing #DigitalTwin #Pharma #TechTransfer --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv
Kymanox
Biotechnology
Morrisville, North Carolina 8,263 followers
Your Life Science Solutions Partner - Bio | Pharma | Device | Combo ...because patients deserve better
About us
Kymanox (‘ki-mah-noks’), meaning Ideal Knowledge Transfer, advances life science innovation through insightful solutions and collaboration. We do this by accelerating the design and commercialization of modern medicines for our customers using integrated engineering, scientific, compliance, and project management solutions that are insightful, collaborative, and comprehensive. By building and supporting the development of modern medicines, Kymanox has proven, end-to-end solutions that are helping bring better Life Science Products to the market- and keep it there. We do all of this with heart and pride… because patients deserve better. Kymanox, founded in 2004, serves clients from Fortune 100 companies to virtual start-up companies all across the globe. Headquartered in Research Triangle Park, NC, we have US offices in Boston and Philadelphia, and since 2022 have expanded to Germany, Switzerland, and Israel.
- Website
-
http://www.kymanox.com
External link for Kymanox
- Industry
- Biotechnology
- Company size
- 201-500 employees
- Headquarters
- Morrisville, North Carolina
- Type
- Privately Held
- Founded
- 2004
- Specialties
- Technical Project Management, Process Operations, Engineering, Commissioning and Validation, Training, FDA PAI Assistance, Sustainability, Combination Products, Tech Transfer, Human Factors, Packaging, Quality Control, CMC Services, Product Development, MS&T, Supply Chain, Clinical Affairs, Regulatory, Medical Affairs, Microbiology & Environmental Monitoring, Audit, and Compliance
Locations
Employees at Kymanox
Updates
-
Kymanox is bringing key insights to two leading industry events! HFES - Human Factors and Ergonomics Society International Healthcare Symposium – Rita Lin, M.S., RAC, Director of Human Factors Engineering, will present on enhancing accessibility & remote monitoring for COPD patients through human factors engineering. Venture Café Cambridge – Jason Martin, MBA, PMP, Senior Director, CGxP Technical Services, will discuss selecting the right CMO to ensure successful drug development & manufacturing. Join us to explore innovations in patient care, pharma manufacturing, and human-centered design! #HFES2025 #HumanFactors #COPD #CMOSelection --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv
-
-
International Women’s Day is more than a celebration—it’s a call to action. #IWD2025 is a reminder that progress accelerates when we take intentional steps toward a more inclusive, equitable future. At Kymanox, we recognize and celebrate the women scientists, leaders, and innovators who drive our mission forward every day. Their work is not only shaping the future of healthcare but also making a tangible difference in patients' lives. To name a few: Nicole Bridgers | QuynhNhu Nguyen | Rita Lin, M.S., RAC | Michelle Frakes, PhD | Katy Rommel, PhD | Rachel Ward | Rahel von Rohr This year, we’re hosting a Lunch & Learn on 18 March, featuring prominent women in our organization who will share their journeys, challenges, and insights. Alexa Burnett | Baileigh Jones, PHR | Allie Hillman | Natalie Hrabrick, PMP. Conversations like these are crucial in building pathways for the next generation of women in science, technology, and leadership. We know there’s always more to do, but today, we celebrate the women making an impact, and we recommit to accelerating action. #AccelerateAction
-
-
To our exceptional Kymanox team worldwide: Your expertise and dedication power our global life science success. From regulatory strategy to technical solutions, you're the leading subject matter experts our clients trust. Across continents, you deliver excellence that transforms healthcare worldwide. Thank you for your commitment to improving lives! Comment below to share your proudest Kymanox moment! #EmployeeAppreciationDay #LifeScience
-
The medical device industry reality: #sterility requirements can't be compromised, yet they're routinely addressed too late in development—leading to validation failures, expensive redesigns, and market delays. Kymanox solves this persistent challenge through proactive #sterilization engineering. Our team integrates sterility considerations from day one of design through full commercialization using a systematic, risk-based approach that: 🔹Reduces development costs 🔹Accelerates market timelines 🔹Maintains unwavering quality standards Ready to integrate sterilization strategy into your development plan? Connect with our specialists contact: [email protected] Next week meet our experts: Shaun Devitt and Josh Earp #regulatory #medicaldevice --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv
-
𝗧𝗵𝗮𝗻𝗸 𝗬𝗼𝘂 𝗳𝗼𝗿 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗞𝗮𝘆 𝗬𝗼𝘄 𝗖𝗮𝗺𝗽𝗮𝗶𝗴𝗻! 🎀 At Kymanox, giving back is at the heart of what we do. Thanks to you, our incredible community, we’ve been able to make a meaningful impact. As part of our Kay Yow Cancer Fund campaign, we pledged to donate $1 for every new follower, and we’re thrilled to share that we’ve contributed $1,000 to support women battling cancer. But our journey didn’t stop there. Our team had the honor of participating in the Kay Yow Celebration Run/Walk 🏃♂️, joining survivors, thrivers, caregivers, and families to celebrate their strength and resilience. While this campaign has ended, the fight against cancer continues. If you’d like to make a difference, you can donate directly to the Kay Yow Cancer Fund here: https://kayyow.com/ Thank you for following, engaging, and standing with us in this mission. A special shoutout to our entire team, especially Jenny Wieboldt and Evan Edwards for their leadership, and Daysia Davenport for building this initiative with us! Together, we can make a difference. 💪 #KayYow #CancerAwareness --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv
-
-
Manufacturing biologics brings endless interfaces: formulation meets container, container meets device, lab work meets production floor. Hanns-Christian Mahler, Founder & CEO ten23 health, shares how bridging these critical gaps helped build a 210-person CDMO powerhouse in just 3 years. Featuring Mathias Romacker, guest host of Life Science Solutions by Kymanox, the key highlights of this podcast are: 🔹Challenging traditional limits in subcutaneous drug delivery 🔹 A comprehensive CDMO approach—integrating development, manufacturing, and testing to create seamless solutions 🔹The power of partnerships—breaking silos between device manufacturers, packaging suppliers, and CDMOs How can we continue to break down these barriers to accelerate innovation? Leave a comment below to share your thoughts. Watch the full podcast on YouTube: https://lnkd.in/ezrceZus --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv
The ten23 health Approach to Biologics Development
https://www.youtube.com/
-
Biomanufacturing’s Big Challenge: How do you optimize complex processes, reduce variability, and scale efficiently—without risking a single batch? Enter 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝘁𝘄𝗶𝗻𝘀—a revolutionary technology that lets you test, refine, and perfect your operations in a virtual environment before making real-world changes. At Kymanox, we believe digital twins are a game-changer for #CDMOs. They enable you to: 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗱𝗼𝘄𝗻𝘁𝗶𝗺𝗲 - Simulate process adjustments before committing to changes. 𝗣𝗿𝗲𝗱𝗶𝗰𝘁 𝗮𝗻𝗱 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 𝗶𝘀𝘀𝘂𝗲𝘀 - Use real-time data to detect failures before they happen. 𝗦𝗰𝗮𝗹𝗲 𝘄𝗶𝘁𝗵 𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 - Model scale-up strategies for seamless tech transfers. This is the first in our Digital Twin Series, written by Rich Motruk, Chief Operating Officer. We’ll explore implementation, scale-up strategies, and regulatory acceptance—giving you the insights you need to stay ahead. Don’t miss out! Subscribe to our newsletter for the latest in biomanufacturing innovation. https://lnkd.in/ex8qyyx2 🔗 Read the full article here: https://lnkd.in/e9TiZUia Next up: 𝘚𝘰 𝘺𝘰𝘶 𝘥𝘦𝘤𝘪𝘥𝘦𝘥 𝘵𝘰 𝘪𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵 𝘢 𝘋𝘪𝘨𝘪𝘵𝘢𝘭 𝘛𝘸𝘪𝘯—𝘸𝘩𝘦𝘳𝘦 𝘥𝘰 𝘺𝘰𝘶 𝘴𝘵𝘢𝘳𝘵? Stay tuned! #digitaltwin #biomanufacturing #lifescience --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv
-
-
Kymanox at DCAT Week in New York! We’re excited to be in New York during DCAT Week, where Evan Edwards (President), Matt Neighoff (Chief Commercial Officer), and Mathias Romacker (Executive Advisor) will be engaging with industry leaders, partners, and innovators. While our schedules are nearly full, we’d love to connect, collaborate, and discuss how Kymanox can support your development and commercialization needs. 🔹 Attending DCAT? Let’s cross paths! 🔹 Want to stay in touch? Reach out anytime at [email protected]. Let’s drive innovation forward—see you in New York! --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv
-
-
Rare Disease Day highlights the 300M+ people worldwide living with rare diseases. At Kymanox, we support innovators developing life-changing therapies—advancing research, regulatory success, & patient access. Let’s drive impact together. If you missed it, we recently wrote an article on the importance of Oligonucleotide Therapeutics and how this supports rare disease and navigating the regulatory complexities. Read the article here, written by Kait Rouillard Vargas, PhD: https://lnkd.in/e9-XeeNn #RareDiseaseDay
-